BEKEMV 300 mg concentrate for solution for infusion
*Company:
Amgen Ireland LtdStatus:
UpdatedLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 20 January 2026
File name
IE_bekemv_approved_pil_ABR Tech transfer.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Addition of site:
Manufacturer
Amgen Europe B.V.
Minervum 7061
4817 ZK Breda
The Netherlands
Updated on 30 October 2025
File name
IE-bekemv_approved-spc_Launch with no CD.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 30 October 2025
File name
IE-bekemv_approved-pil_Launch with no CD.pdf
Reasons for updating
- New PIL for new product
File name
BEKEMV IE Patient Parent Caregiver Guide Sept 2025.pdf
Reasons for updating
- Add New Doc
File name
BEKEMV IE Patient Card Sept 2025.pdf
Reasons for updating
- Add New Doc
File name
BEKEMV IE HCPS Guide Sept 2025.pdf
Reasons for updating
- Add New Doc
Amgen Ireland Ltd
Address:
21 Northwood Court, Santry, Dublin D09 TX31, Ireland, 216 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WA, UKMedical Information E-mail:
gbinfoline@amgen.comTelephone:
+44 (0)1223 420 305Website:
https://www.amgen.co.ukMedical Information Direct Line:
+44 (0)1223 436 441/Freephone: 1800 535160Customer Care direct line:
+44 (0)1223 436441/Freephone: 1800 535160